News | January 18, 2010

Mayo Backs Breast Screening at Age 40

January 18, 2010 - Mayo Clinic announced its recommendation on breast cancer screening continues to be annual screening at age 40, however, it acknowledges that women need to be informed about its benefits, risks and limitations.

The U.S. Preventive Services Task Force (USPSTF) recommended in November 2009 that routine breast cancer screening begin at age 50, instead of 40 as previously advised. Discussions in the Senate and the House are leading toward an amendment in the pending healthcare bill that would provide insurance coverage for annual mammograms beginning at age 40.

"Evidence continues to support the role of mammograms in reducing breast cancer mortality — they are the best screening tool available today," said Sandhya Pruthi, M.D., director of Mayo Clinic's Breast Clinic in Rochester, Minn.

"To address the concerns raised by the USPSTF regarding the false positives associated with screening mammograms, more emphasis needs to be placed on improving accuracy of mammograms, referrals to breast imaging centers where digital mammograms and core needle biopsies are available — and patients need to receive timely and coordinated care to alleviate anxiety.

Individualized risk assessment may be the next step in deciding who is at increased risk and when and how often screening should occur. Health care providers need risk assessment tools designed for individualized risk, not population risk."

Ongoing research at Mayo Clinic is studying ways to improve breast cancer risk stratification. Dr. Pruthi says further research is also critical to better understand tumor biology and to develop biomarkers or tests for early detection.

"We also need better ways to communicate risk and help patients understand how to weigh the risks versus benefits of screening mammograms," she said. "An amendment in the healthcare bill to provide coverage for annual mammography screening is important and would certainly maintain our ability to provide quality preventive care to women."

For more information: www.mayoclinic.com

Related Content

Fujifilm Announces Nationwide Breast Health Campaign With Mobile Mammography Coach

At the center of the campaign, Fujifilm will be traveling around the U.S. with its "Aspire to Be Fearless" mobile mammography coach to provide educational opportunities for clinicians, raise awareness about the importance of screening and will be providing mammograms to the underserved population in key locations.

News | Mammography | June 14, 2019
Fujifilm Medical Systems U.S.A. Inc. announced a nationwide awareness campaign titled ‘Aspire to Be Fearless’ focused...
Ikonopedia Showcases Risk Assessment and Resolution Manager Tools at SIIM and AHRA
News | Mammography Reporting Software | June 13, 2019
Ikonopedia will showcase its suite of structured breast reporting and Mammography Quality Standards Act (MQSA)...
iCAD Introduces ProFound AI for 2D Mammography in Europe
News | Artificial Intelligence | June 13, 2019
iCAD Inc. announced the launch of ProFound AI for 2D Mammography in Europe. This software is the latest addition to...
Three Palm Software Releases WorkstationOne Version 1.8.8
Technology | Mammography Reporting Software | June 12, 2019
Three Palm Software announced the release of the 1.8.8 version of its breast imaging workstation, WorkstationOne. This...
Volpara Health Technologies to Acquire MRS Systems Inc.
News | Mammography Reporting Software | June 04, 2019
Volpara Health Technologies, Volpara Solutions' parent company, has signed a binding agreement to acquire U.S.-based...
62-year-old female patient presenting for 3D screening mammogram. Location of an indeterminate low-density circumscribed mass was not clearly determined as at the skin line or just under the surface.

62-year-old female patient presenting for 3D screening mammogram. Location of an indeterminate low-density circumscribed mass was not clearly determined as at the skin line or just under the surface.

Feature | Mammography | May 31, 2019 | By Olive Peart M.S., R.T.(R)(M)
In recent years there has been a lot of debate about the role of the...
VolparaDensity With Tyrer-Cuzick Model Improves Breast Cancer Risk Stratification
News | Breast Density | May 22, 2019
Research has demonstrated use of Volpara Solutions' VolparaDensity software in combination with the Tyrer-Cuzick Breast...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Novel Artificial Intelligence Method Predicts Future Risk of Breast Cancer
News | Artificial Intelligence | May 08, 2019
Researchers from two major institutions have developed a new tool with advanced artificial intelligence (AI) methods to...
Georgia Becomes 38th State With Breast Density Inform Law
News | Breast Density | May 06, 2019
Georgia Gov. Brian Kemp signed breast density inform bill HB62 into law May 3, 2019. The law, which becomes effective...